Literature DB >> 21803020

Important parameters for evaluation of antibody avidity by immunosorbent assay.

Jordan D Dimitrov1, Sebastien Lacroix-Desmazes, Srinivas V Kaveri.   

Abstract

The evaluation of antibody avidity by elution with chaotropic agents is a frequently used approach in research and diagnostics. It provides important information on the functional relevance of antibodies. However, in the literature, there is a large heterogeneity in the experimental settings for the determination of this important parameter. Here, we demonstrate that antibody concentration and the choice of chaotropic agent are critical for the reliable estimation of antibody avidity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21803020     DOI: 10.1016/j.ab.2011.07.007

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  21 in total

1.  What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?

Authors:  Marina R Alexander; Rajesh Ringe; Rogier W Sanders; James E Voss; John P Moore; Per Johan Klasse
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

2.  IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine.

Authors:  Sanghita Sarkar; Michael S Piepenbrink; Madhubanti Basu; Juilee Thakar; Michael C Keefer; Ann J Hessell; Nancy L Haigwood; James J Kobie
Journal:  Vaccine       Date:  2019-03-27       Impact factor: 3.641

3.  Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.

Authors:  Raïssa Nadège Caboré; Kirsten Maertens; Alexandre Dobly; Elke Leuridan; Pierre Van Damme; Kris Huygen
Journal:  Virulence       Date:  2017-02-22       Impact factor: 5.882

4.  Characterization of pandemic influenza immune memory signature after vaccination or infection.

Authors:  Olivia Bonduelle; Fabrice Carrat; Charles-Edouard Luyt; Catherine Leport; Anne Mosnier; Nora Benhabiles; Anne Krivine; Flore Rozenberg; Nora Yahia; Assia Samri; Dominique Rousset; Sylvie van der Werf; Brigitte Autran; Behazine Combadiere
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

5.  Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection.

Authors:  Chien-Chia Chen; Eric Pouliquen; Alexis Broisat; Francesco Andreata; Maud Racapé; Patrick Bruneval; Laurence Kessler; Mitra Ahmadi; Sandrine Bacot; Carole Saison-Delaplace; Marina Marcaud; Jean-Paul Duong Van Huyen; Alexandre Loupy; Jean Villard; Sandrine Demuylder-Mischler; Thierry Berney; Emmanuel Morelon; Meng-Kun Tsai; Marie-Nathalie Kolopp-Sarda; Alice Koenig; Virginie Mathias; Stéphanie Ducreux; Catherine Ghezzi; Valerie Dubois; Antonino Nicoletti; Thierry Defrance; Olivier Thaunat
Journal:  J Clin Invest       Date:  2017-11-20       Impact factor: 14.808

6.  Comparison of different enzyme-linked immunosorbent assay methods for avidity determination of antiphospholipid antibodies.

Authors:  Lenka Fialová; Milada Petráčková; Oliver Kuchař
Journal:  J Clin Lab Anal       Date:  2017-01-26       Impact factor: 2.352

7.  The interaction of anti-DNA antibodies with DNA antigen: Evidence for hysteresis for high avidity binding.

Authors:  David S Pisetsky; Robert Shaffer; Dustin D Armstrong; Diane M Spencer
Journal:  Clin Immunol       Date:  2021-09-04       Impact factor: 10.190

8.  Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine.

Authors:  Mohammad Murshid Alam; Daniel T Leung; Marjahan Akhtar; Mohammad Nazim; Sarmin Akter; Taher Uddin; Farhana Khanam; Deena Al Mahbuba; Shaikh Meshbahuddin Ahmad; Taufiqur Rahman Bhuiyan; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2013-08-07

Review 9.  How to assess the binding strength of antibodies elicited by vaccination against HIV and other viruses.

Authors:  P J Klasse
Journal:  Expert Rev Vaccines       Date:  2016-01-06       Impact factor: 5.217

10.  The avidity of PR3-ANCA in patients with granulomatosis with polyangiitis during follow-up.

Authors:  M J Kemna; W Schlumberger; P van Paassen; C Dähnrich; J G M C Damoiseaux; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2016-05-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.